The fundamental difference is the source. MCT Exosomes are autologous — derived from your own blood — which means they carry no risk of immune rejection. Non-autologous exosome products, sourced from plants or donors, are approved for topical use only and cannot be injected. The MCT System is certified to the highest international medical device standards and validated across multiple clinical disciplines.

Three sessions spaced three weeks apart is our standard protocol, though this is always tailored individually. Results are progressive — continuing to develop in the weeks following treatment as your cells' own regeneration builds.

The treatment involves a blood draw and a series of small injections, with topical anaesthesia applied to minimise discomfort. Downtime is typically minimal — some patients experience mild redness at the injection site, which resolves quickly. Because the treatment uses your own biology, the inflammatory response is far lower than with synthetic injectables.

Yes — and combination protocols are often where the most significant results are seen. MCT Exosomes work particularly well alongside my signature injectable treatments, laser procedures or Profhilo, reducing recovery time and amplifying the regenerative response. Your programme will be designed holistically during your initial consultation.

The Exo C Booster and the MCT clinic treatment share the same philosophy — harnessing exosome science to reactivate the skin's regenerative capacity — but operate on different levels. The Exo C Booster uses plant-derived exosomes for daily at-home use; the clinic treatment uses injectable autologous exosomes from your own biology for deep clinical regeneration. Used together, they form a complete approach to skin longevity.